{'fraction_non_alphanumeric': 0.02361111111111111, 'fraction_numerical': 0.0, 'mean_word_length': 5.80188679245283, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Impact of Global Integration on Drug Development and Clinical Research

Global integration has brought sweeping changes in the pharmaceutical industry due to cost constraints that have forced the industry to negotiate for lower “bottom line” costs. The pharmaceutical industry is constantly and rapidly changing because of changes in technology, research and development (R&D), regulations, competition, and demand for pharmaceuticals. Increased competition will drive industry change as the use of less expensive generic and over-the-counter drugs increases because of the rise in managed health care. Companies will focus on streamlining production methods, reducing product development cycles, and reducing costs.